Board Meeting30 Oct 2026, 08:30 pm
Sudarshan Pharma to Raise ₹72 Cr Via Convertible Warrants
AI Summary
Sudarshan Pharma Industries Ltd announced that its Board of Directors has approved a proposal to raise up to ₹72,00,00,000 (₹72 Crore) through the issuance and allotment of Convertible Warrants on a preferential basis to promoters Mr. Hemal Mehta and Mr. Sachin Mehta. Each warrant is convertible into one equity share. The issuance price will be determined as per SEBI ICDR Regulations. The company will seek shareholder approval at an upcoming Extraordinary General Meeting (EGM).
Key Highlights
- Board approves raising ₹72 Crore via convertible warrants.
- Warrants to be issued preferentially to promoters.
- Shareholder approval required via EGM.
- Funds to be raised under SEBI ICDR Regulations.
Price Impact
More from SUDARSHAN